RESECTABLE HEPATOCELLULAR CARCINOMA
Clinical trials for RESECTABLE HEPATOCELLULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RESECTABLE HEPATOCELLULAR CARCINOMA trials appear
Sign up with your email to follow new studies for RESECTABLE HEPATOCELLULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New combo therapy aims to shrink liver tumors before surgery
Disease control Recruiting nowThis early-phase study tests whether combining targeted radiation beads (SIRT) with two immunotherapy drugs (tremelimumab and durvalumab) is safe and effective before liver cancer surgery. About 20 adults with resectable liver cancer will receive the treatment and then undergo su…
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: Jiping Wang, MD, PhD • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New PET tracer could sharpen liver cancer detection
Diagnosis Recruiting nowThis study is testing a new imaging agent called 18F-FSPG for PET scans to see if it can find liver cancer more accurately than current methods. About 110 adults with liver tumors will get this scan before their planned surgery or transplant. The goal is to improve diagnosis and …
Matched conditions: RESECTABLE HEPATOCELLULAR CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated May 22, 2026 13:54 UTC